Programador HTA (SAS/R) - AMNOG & Market Access (Remote)

Talink Enlace de Talento

Albacete

Hybrid

EUR 50,000 - 70,000

Full time

2 days ago

Be an early applicant

Application generator

Stand out for this role — generate a tailored resume and cover letter in about a minute.

Get past ATS filters

Job summary

IQVIA is seeking a Programmer (SAS & R) with German to support health technology assessment (AMNOG) and market access activities in Germany. The role is based in Madrid, Spain with remote or hybrid options, and targets biostatisticians or data scientists with a strong interest in applying clinical evidence to reimbursement and decision‑making.

A substantial part involves statistical programming. You will develop German AMNOG dossiers (Module 4), analyze clinical trial data, perform meta

Qualifications

Master's degree or PhD in biostatistics, data science, or a related field.
Initial experience in HTA, AMNOG, HEOR, or Market Access (industry, consultancy, or research institute preferred) and/or in clinical development.
Solid understanding of clinical study designs, endpoints, and statistical principles.
Familiarity with clinical study data and the corresponding industry standards (CDISC SDTM/ADaM).
Familiarity with the German AMNOG process, IQWiG methodology, or G‑BA procedures is an advantage.

Responsibilities

Contribute to the development of German AMNOG dossiers, with a focus on programming of statistical analyses for Module 4
Perform scientific assessment and analysis of clinical trial data, including analysis of efficacy, safety, patient-relevant endpoints, and subgroup analyses
Perform meta-analyses and indirect treatment comparisons and support interpretation of statistical outputs
Contribute to the automation and standardization of analysis workflows to ensure efficiency, consistency, and reproducibility
Collaborate closely with cross functional teams (Market Access, HEOR, Medical Affairs, EU-HTA Team)
Ensure scientific quality, clarity, and consistency of generated outcomes
Monitor and interpret methodological developments from IQWiG, G‑BA, and relevant HTA bodies